Latest news
CG Oncology publishes investor deck highlighting cretostimogene data in high-risk NMIBC programs - BitgetBitget · Thu, 06 Aug 2026 05:04:15 GMTAndrea Necchi: A Combined Analysis of PURE01 and SURE02 - OncodailyOncodaily · Tue, 04 Aug 2026 19:04:50 GMTBOND-003 Phase 3: Cretostimogene Shows 75% Complete Response Rate in BCG-Unresponsive NMIBC - OncodailyOncodaily · Sat, 01 Aug 2026 09:50:17 GMTDurable Responses Seen With Cretostimogene in BCG-Unresponsive NMIBC - Targeted OncologyTargeted Oncology · Wed, 29 Jul 2026 07:00:00 GMTCretostimogene Grenadenorepvec Shows Complete Responses in NMIBC - CancerNetworkCancerNetwork · Tue, 28 Jul 2026 17:08:36 GMT